Laboratory immunoassay workflow
EXI CLIA routes support laboratory hormone, thyroid, fertility, infectious-disease, tumor-marker, and specialty immunoassay planning.
Berhan Pharma supports hormone analyzer procurement across CLIA and POCT immunoassay routes, including thyroid, fertility, vitamin D, hormone, inflammation, cardiac-marker, and specialty testing contexts for Ethiopian institutions.
Product families, clinical use cases, and procurement routes for Ethiopian institutions.
EXI CLIA routes support laboratory hormone, thyroid, fertility, infectious-disease, tumor-marker, and specialty immunoassay planning.
EXR and Q8 Pro routes support near-patient testing where rapid clinical decisions and decentralized workflows matter.
Hormone analyzer quotations should confirm analyte menu, sample type, reagent availability, controls, throughput, and reporting needs.
Technical points buyers should define before quotation, tender submission, or model shortlisting.
Use CLIA for laboratory automation and POCT for rapid decentralized testing, subject to menu requirements.
Model choice depends on throughput, menu, urgency, sample workflow, and department.
Final assay availability must be confirmed with current manufacturer and supply information.
A useful request should include desired tests and expected daily workload.
Useful product pages, company documents, quality controls, and contact routes for institutional review.
Public business details, support channels, and document paths for procurement teams reviewing Berhan Pharma.
This page gives hormone analyzer and thyroid/fertility testing searches a dedicated local Ethiopia entry point.
The page explains when buyers may review laboratory CLIA routes versus compact point-of-care immunoassay routes.
Buyers can submit target analyte menu, workload, urgency, sample type, and reporting requirements for technical confirmation.